MALVERN, PA — HMP Global has unveiled a new identity for its market access division, rebranding HMP Market Access Insights as MARIN (Market Access Research Intelligence). The change underscores the division’s growing role in delivering actionable insights and strategies to biopharmaceutical manufacturers in the oncology sector.
The rebrand follows HMP Global’s acquisition of Proximity Health, LLC, in 2022 and establishes MARIN as a forward-thinking brand equipped to meet the increasing complexities of oncology care. With over 20 years of experience, the MARIN team continues to provide critical research and intelligence to support biopharmaceutical innovation.
“MARIN represents our commitment to clarity and precision in the oncology space,” said Jeff Hennessy Jr., COO of HMP Global. “By combining advanced methodologies with deep market expertise, we empower clients to optimize their market access strategies.”
MARIN’s enhanced offerings include the flagship Oncology Customer Segment Report Series and a comprehensive IDN Annual Trend Report, set for release this spring. Additional capabilities span proprietary account-specific data, expert consultations, and regular delivery of actionable intelligence, all designed to help clients address evolving challenges and seize opportunities in the oncology market.
The rebrand is marked by a fresh visual identity and a dedicated website, enabling easy access to resources and reports. MARIN’s transformation affirms its position as a leader in market access research, poised to drive meaningful impact in advancing oncology care.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.